CWK-23439-94318
3 vaccinations
10 coded responses
29 check-ins
10 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 981 / WA
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
PML-31967-09020
Child or adolescent in my care · Male · 2022-01-28
NSW-19651-91120
Child or adolescent in my care · Male · 2022-01-28
SDX-26157-20090
Child or adolescent in my care · Female · 2022-01-28
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Moderna
- 2020-12-31
-
2021-01-01
Survey response — days 1–6 daily, dose 1MedDRA: Conjunctivitis allergic — Feeling: Good · Site: PainFree text: Allergic conjunctivitisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-07
-
2021-01-14
Survey response — day 14, dose 1MedDRA: Arthralgia, Injection site reaction, Loss of personal independence in daily activities — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: 5cm itchy rash at injection site (developed on 1/8, eight days after injection) with associated arthralgias that impaired ADLs. Both symptoms lasted 48 hours and resolved.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Report sent to call center — day 14, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-21
-
2021-01-28
Dose 2 — Moderna
-
2021-01-28
Survey response — day 0, dose 2MedDRA: Conjunctivitis allergic — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessFree text: Allergic conjunctivitis (had this with first shot, too)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-29
Survey response — days 1–6 daily, dose 2MedDRA: Conjunctivitis allergic, Supraventricular tachycardia — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: SVT, Allergic conjunctivitisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Survey response — days 1–6 daily, dose 2MedDRA: Conjunctivitis allergic — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Allergic conjunctivitisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Conjunctivitis allergic — Feeling: Good · Fatigue or tirednessFree text: Allergic conjunctivitisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
-
2021-02-11
Survey response — day 14, dose 2MedDRA: Arthralgia, Lymphadenopathy, Reaction to previous exposure to any vaccine — Feeling: GoodFree text: Arthralgias (similar to after my first shot) and left axillary adenopathy noted on my mammogram (requires f/u ultrasound). NO delayed onset of rash this time.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-08
-
2021-03-09
Call successfulParticipant prefers to complete VAERS report online
- 2021-03-11
- 2021-04-29
- 2021-07-29
-
2021-11-09
Dose 3 — Moderna
-
2022-01-28
Survey response — 12 months, dose 2MedDRA: Urticaria chronic — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Chronic urticaria, continuous since 11/20/2021MedDRA releases: 2024-11 · check-in free text available
-
2022-01-28
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-01
Call successfulNot applicable - Accidental Reporting
- 2022-02-08
-
2022-05-10
Survey response — 6 months, dose 3MedDRA: Urticaria — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Ongoing hives over my whole body since third covid vaccine in Nov 2021 (6 months now)MedDRA releases: 2024-11 · check-in free text available
-
2022-05-10
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-11
-
2022-05-11
Callback requested for02:40PM ET
-
2022-05-11
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2022-11-09
Survey response — 12 months, dose 3MedDRA: Urticaria — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Continue to have hives since covid booster in Nov 2021 (almost a year ago)MedDRA releases: 2024-11 · check-in free text available
-
2022-11-09
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-11-10
Call successfulReported to VAERS voluntarily prior to GDIT contact
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Moderna | |
| 2 | 2021-01-28 | Moderna | |
| 3 | 2021-11-09 | Moderna | No |
Call center
4 call center cases
4 successful
VAERS report filed, before or during a call: 2
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Allergic conjunctivitis
Release 2 — day 14, dose 1
Symptoms: 5cm itchy rash at injection site (developed on 1/8, eight days after injection) with associated arthralgias that impaired ADLs. Both symptoms lasted 48 hours and resolved.
Release 2 — day 0, dose 2
Systemic reaction (other): Allergic conjunctivitis (had this with first shot, too)
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): SVT, Allergic conjunctivitis
Systemic reaction (other): Allergic conjunctivitis
Systemic reaction (other): Allergic conjunctivitis
Release 4 — day 14, dose 2
Symptoms: Arthralgias (similar to after my first shot) and left axillary adenopathy noted on my mammogram (requires f/u ultrasound). NO delayed onset of rash this time.
Release 11 — 12 months, dose 2
Symptoms: Chronic urticaria, continuous since 11/20/2021
Release 11 — 6 months, dose 3
Symptoms: Ongoing hives over my whole body since third covid vaccine in Nov 2021 (6 months now)
Release 12 — 12 months, dose 3
Symptoms: Continue to have hives since covid booster in Nov 2021 (almost a year ago)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Injection site reaction | ✓ | ✓ | ✓ |
| SD | Loss of personal independence in daily activities | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Reaction to previous exposure to any vaccine | ✓ | ✓ | ✓ |
| SD | Urticaria | · | · | ✓ |
| SD | Urticaria chronic | · | · | ✓ |
| SRO | Conjunctivitis allergic | ✓ | ✓ | ✓ |
| SRO | Supraventricular tachycardia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release